Amyloidosis News and Research

RSS
Amyloidosis is the term applied to a group of conditions caused by deposits of an abnormal protein called amyloid. This rare but serious condition affects between 1 and 5 people in every 100,000 each year in the UK. The condition is mainly seen among the elderly.
Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Solution for treating obesity-related diseases may reside in fat tissue

Solution for treating obesity-related diseases may reside in fat tissue

Adipose tissue might serve as target for treating obesity-related disorders

Adipose tissue might serve as target for treating obesity-related disorders

Amyloid peptide Aβ43 may serve as biomarker for diagnosis of Alzheimer's

Amyloid peptide Aβ43 may serve as biomarker for diagnosis of Alzheimer's

Potential new approach for treating myelofibrosis

Potential new approach for treating myelofibrosis

Genomic study identifies MCU that regulates calcium transport into mitochondria

Genomic study identifies MCU that regulates calcium transport into mitochondria

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011

Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011

Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study

Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Alnylam to extend RNAi therapeutics research collaboration with AlCana and UBC

Alnylam to extend RNAi therapeutics research collaboration with AlCana and UBC

Alnylam defends against Tekmira complaint, files answer and counterclaim

Alnylam defends against Tekmira complaint, files answer and counterclaim

Discovery of 4 new genes associated with Alzheimer's

Discovery of 4 new genes associated with Alzheimer's

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Protein aggregation plays a significant role in cancer

Protein aggregation plays a significant role in cancer

First continuous-flow total artificial heart transplant performed at THI

First continuous-flow total artificial heart transplant performed at THI

Alnylam to defend against Tekmira complaint

Alnylam to defend against Tekmira complaint

Global settlement agreement reached in Tuschl patents litigation

Global settlement agreement reached in Tuschl patents litigation

Nephros completes its shareholders rights offering, related private placement financing

Nephros completes its shareholders rights offering, related private placement financing